Concomitant left main coronary artery and prosthetic mitral valve thrombosis treatment

Significant left main coronary artery (LMCA) thrombosis has a 40%–80% mortality, and the treatment strategy is determined from experience in LMCA stenosis in nonacute cases (1). Coronary revascularization guidelines lack clear Class I suggestion for the management of prosthetic valve thrombosis owing to the lack of randomized trials and leave the choice of treatment to physicians (2). Here we describe a treatment approach used in a patient with combined LMCA thrombosis and PVT.